Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 5.44
-0.11 (-1.90%)
Sep 11, 2026, 4:08 PM HKT
HKG:0719 Revenue
Shandong Xinhua Pharmaceutical Company had revenue of 1.93B CNY in the quarter ending June 30, 2026, a decrease of -12.43%. This brings the company's revenue in the last twelve months to 8.47B, up 1.20% year-over-year. In the year 2025, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.75B with 3.41% growth.
Revenue (ttm)
8.47B CNY
Revenue Growth
+1.20%
P/S Ratio
0.88
Revenue / Employee
1.17M CNY
Employees
7,240
Market Cap
8.57B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.75B | 288.41M | 3.41% |
| Dec 31, 2024 | 8.47B | 365.47M | 4.51% |
| Dec 31, 2023 | 8.10B | 597.86M | 7.97% |
| Jan 1, 2023 | 7.50B | 942.91M | 14.37% |
| Dec 31, 2021 | 6.56B | 554.49M | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 14.68B |
| Luye Pharma Group | 7.08B |
| SSY Group | 4.38B |
| Consun Pharmaceutical Group | 4.19B |
| China Shineway Pharmaceutical Group | 3.08B |
| Sihuan Pharmaceutical Holdings Group | 3.04B |
| CanSino Biologics | 1.43B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.35B |
Shandong Xinhua Pharmaceutical Company News
- 6 months ago - Viral dance challenge lifted Chinese ibuprofen maker’s shares – now they are languishing - South China Morning Post